Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.

Autor: Adhami M; Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., MotieGhader H; Department of Computer Engineering, Gowgan Educational Center, Tabriz Branch, Islamic Azad University, Tabriz, Iran., Haghdoost AA; Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Afshar RM; Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran., Sadeghi B; Food Hygiene and Public Health Department, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran. Electronic address: sadeghi.balal@uk.ac.ir.
Jazyk: angličtina
Zdroj: Genomics [Genomics] 2020 Jan; Vol. 112 (1), pp. 135-143. Date of Electronic Publication: 2019 Feb 05.
DOI: 10.1016/j.ygeno.2019.01.010
Abstrakt: New diagnostic miRNA biomarkers for different types of cancer have been studied extensively, particularly for breast cancer (BC), which is a leading cause of death among women and has many different subtypes. In the present study, a systems biology approach was used to find remarkable and novel miRNA biomarkers for five molecular subtypes of BC: luminal A, luminal B, ERBB2, basal-like and normal-like. The mRNA expression data from the five BC subtypes was used to reconstruct co-expression networks. The important mRNA-miRNA interactions were considered when reconstructing the bipartite networks from which the five bipartite sub-networks were reconstructed for further analysis. The novel biomarkers detected for each subtype are as follows: miRNAs 26b-5p and 124-3p for basal-like, 26b-5p, 124-3p and 5011-5p for ERBB2, 26b-5p and 5011-5p for LumA, 124-3p, 26b-5p and 7-5p for LumB and 26b-5p, 124-3p and 193b-3p for normal-like. The roles of the identified miRNAs in the occurrence or development of each subtype of BC remain unclear and should be investigated in future studies. In addition, the target genes of these miRNAs may be critical to the mechanisms underlying each subtype and should be analyzed as therapeutic targets in future studies.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE